Novacyt S.A. (AIM:NCYT)
London · Delayed Price · Currency is GBP · Price in GBX 34.00
+0.72 (2.13%)
Feb 13, 2026, 4:28 PM GMT
Novacyt Market Cap
Novacyt has a market cap or net worth of 25.05 million as of February 13, 2026. Its market cap has decreased by -31.10% in one year.
Market Cap
25.05M
Enterprise Value
12.08M
Revenue
19.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.00
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 18.97M to 25.05M, an increase of 32.05%. That is a compound annual growth rate of 2.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 24.17M | 0.50% |
| Dec 31, 2025 | 24.05M | -31.52% |
| Dec 31, 2024 | 35.12M | -19.57% |
| Dec 29, 2023 | 43.67M | -43.27% |
| Dec 30, 2022 | 76.97M | -70.37% |
| Dec 31, 2021 | 259.78M | -58.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| ImmuPharma | 31.72M |
| Arecor Therapeutics | 27.94M |
| Abingdon Health | 26.00M |
| Sareum Holdings | 24.85M |